Autologous Dendritic Cell Vaccine (Hasumi International Research Foundation)

自体树突状细胞疫苗 (Hasumi International Research Foundation)

Report date: 2026/03/06 20:02:51

Base Information

Drug NameAutologous Dendritic Cell Vaccine (Hasumi International Research Foundation)

Drug Alias NameN/A

ClassificationVaccines > Development/production technology > Dendritic cell vaccineCell and gene therapy > Cell therapy > Immune system cell therapy > Dendritic cell therapy > Dendritic cell vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsUveal melanoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryGermany

CombinationsNo

Global Highest StatusPhase 1 Clinical

Highest Status in ChinaN/A

Originator CompaniesHasumi International Research Foundation

China Registration ClassN/A

Develop Information

Active CompaniesHasumi International Research Foundation

Inactive CompaniesN/A

Active IndicationsUveal melanoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A